B-Lymphoblastic Leukemia With Aberrant CD5 Expression

Online journal article in Hematopathology that offers 1.0 continuing education (CME) credit that can be used to fulfill CC Part II requirements.

Quantity:

Want to save more?

Log into see if you qualify for a lower rate.

Members

save $5.00 or more

Intended Audience: Pathologists, Residents, Clinical Scientists, Pathologist Assistants

Upon completion of this activity, you will be able to:

Discuss the impact of CD5 expression in B-acute lymphoblastic leukemia (B-ALL) on clinical outcome treatment planning.
List the differential diagnoses of...

Intended Audience: Pathologists, Residents, Clinical Scientists, Pathologist Assistants

Upon completion of this activity, you will be able to:

Discuss the impact of CD5 expression in B-acute lymphoblastic leukemia (B-ALL) on clinical outcome treatment planning.
List the differential diagnoses of CD5-positive B-cell hematopoietic neoplasms with blastic morphology.

View More View Less